Gilkeson Research Lab

Gary Gilkeson, M.D.
Distinguished University Professor
Division of Rheumatology & Immunology
Associate Dean for Faculty Affairs & Faculty Development

 

 

Research Interests:

Dr. Gilkeson’s research focuses on the pathogenesis and treatment of systemic lupus erythematosus. His major focus is on the use of mesenchymal stromal cells as a treatment for refractory lupus patients. He is the sponsor of an investigator initiated multicenter double blind placebo controlled trial of umbilical cord MSCs in treating refractory lupus patients. Extensive mechanistic studies of immune parameters are being performed in this trial of 81 participants. He is also a co-PI of a study looking at B cell heterogeneity in Black women with lupus in collaboration with investigators at UAB and Emory. Dr. Wei Jiang in Immunology at MUSC is performing plasma microbiome analysis to determine any correlates with B cell phenotype and/or disease parameters. Dr. Gilkeson is involved in a study of autoantibodies to extracellular antigens in patients with lupus working with a company Seranova. Over 4,000 samples collected chronologically are being studied for the presence of autoantibodies to over 10,000 antigens, correlating with disease activity. His clinic contributes to the rheumatology biorepository.

Publications:

PubMed Collection

Senior Author Publications:

Senior Author PubMed Collection (senior author publications are most often associated with mentored projects)